Ohtuvayre™is indicated for the maintenance treatment of chronic obstructive pulmonary disease (COPD) in adult patients ...

and now Verona has revealed the drug made approximately $36 million in the final three months of 2024, off more than 16,000 prescriptions. Chief executive David Zaccardelli said Ohtuvayre was off ...

David Zaccardelli, Pharm. D., President and Chief Executive Officer of Verona Pharma, said: "We are very pleased that Ohtuvayre TM is available to help patients still experiencing daily COPD symptoms.

Ohtuvayre is due to launch in the US in the third quarter of this year, assisted by a $650 million debt facility that Verona agreed a few months ago to build its commercial capabilities.

VERONA, Italy :Atalanta thrashed lowly Hellas Verona 5-0 in Serie A on Saturday, with Italian striker Mateo Retegui scoring four times including a hat-trick before the break. Retegui, the league's ...

Piper Sandler analyst Yasmeen Rahimi maintained a Buy rating on Verona Pharma (VRNA – Research Report) today and set a price target of $76.00. The company’s shares closed yesterday at $59.94.

SHANGHAI, Feb. 7, 2025 /PRNewswire/ -- Today, Nuance Pharma ("Nuance") announced that the Pharmaceutical Administration Bureau Macau approved Ohtuvayre™ (ensifentrine) for the maintenance ...

ROME (AP) — Mateo Retegui scored four goals to lead Atalanta’s 5-0 demolition of Hellas Verona in Serie A on Saturday. The Italy striker took his league-leading tally to 20 goals for the ...